Targeted Therapy Shows Promise in Rare Bile Duct Cancer Phase II Trial
Investigators have reported positive clinical outcomes from a Phase II trial evaluating a targeted therapy for cholangiocarcinoma, a rare and aggressive form of bile duct cancer. The study demonstrates improved ... Read More